Header Logo

Connection

JACK SU to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications JACK SU has written about Receptor, ErbB-2.
JACK SU
Connection Strength
0.028
Receptor, ErbB-2
  1. HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. JAMA Oncol. 2017 Aug 01; 3(8):1094-1101.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.